Hyojin Park Selected Research

polaprezinc (Z 103)

1/2021

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyojin Park Research Topics

Disease

13	Neoplasms (Cancer) 05/2022 - 07/2013
11	Esophageal Achalasia (Megaesophagus) 04/2022 - 07/2013
8	Stomach Neoplasms (Stomach Cancer) 05/2022 - 03/2012
7	Dyspepsia (Indigestion) 01/2021 - 01/2012
7	Gastroesophageal Reflux (GERD) 01/2021 - 04/2013
5	Ileus 10/2021 - 07/2013
5	Heartburn (Pyrosis) 04/2021 - 01/2016
5	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2014 - 01/2004
4	Carcinogenesis 03/2022 - 01/2022
4	Eosinophilic Esophagitis 06/2021 - 11/2014
4	Inflammation (Inflammations) 01/2018 - 12/2004
4	Deglutition Disorders (Dysphagia) 01/2016 - 04/2013
3	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 04/2015
3	Diarrhea 10/2018 - 01/2013
3	Eosinophilia 07/2018 - 04/2013
3	Infections 06/2018 - 01/2012
2	Hypoxia (Hypoxemia) 01/2022 - 08/2014
2	Non-Erosive Reflux Disease 04/2021 - 01/2021
2	Ulcer 01/2021 - 01/2016
2	Gastric Outlet Obstruction 05/2020 - 01/2013
2	Peptic Esophagitis (Reflux Esophagitis) 11/2019 - 10/2014
2	Adenoma (Adenomas) 10/2019 - 01/2013
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 11/2015
2	Peritoneal Neoplasms 12/2018 - 06/2018
2	Hemorrhage 01/2018 - 02/2017
2	Hypersensitivity (Allergy) 04/2016 - 12/2015
2	Esophageal Motility Disorders (Nutcracker Esophagus) 01/2016 - 01/2014
2	Colitis 01/2012 - 12/2004
1	Ankylosing Spondylitis 01/2022
1	Rheumatoid Arthritis 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Ulcerative Colitis 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Atrophic Gastritis 01/2022
1	Metaplasia 01/2022
1	Precancerous Conditions 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Vascular Malformations 01/2021
1	Hereditary Hemorrhagic Telangiectasia 01/2021
1	Sarcopenia 01/2019
1	Carcinoma (Carcinomatosis) 12/2018
1	Peptic Ulcer (Peptic Ulcers) 01/2018

Drug/Important Bio-Agent (IBA)

9	Proton Pump InhibitorsIBA 01/2021 - 04/2013
6	Pharmaceutical PreparationsIBA 10/2021 - 11/2012
5	AcidsIBA 04/2021 - 12/2015
4	Triglycerides (Triacylglycerol)IBA 03/2022 - 01/2017
4	Pantoprazole (Protonix)FDA LinkGeneric 04/2021 - 09/2014
4	Serotonin (5 Hydroxytryptamine)IBA 01/2013 - 01/2004
3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2022
3	DA-9701IBA 07/2016 - 07/2015
3	Biological ProductsIBA 04/2016 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2016
2	ORALIT (ORS)IBA 01/2022 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2018
2	mosaprideIBA 01/2021 - 10/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 11/2013
2	CU06-1004IBA 01/2017 - 08/2014
2	ramosetron (Nasea)IBA 04/2013 - 01/2013
2	Lactulose (Duphalac)FDA LinkGeneric 07/2011 - 10/2010
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 09/2005 - 01/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2004 - 01/2004
1	ParaffinIBA 05/2022
1	Formaldehyde (Formol)FDA Link 05/2022
1	RNA (Ribonucleic Acid)IBA 05/2022
1	WD repeat containing planar cell polarity effectorIBA 05/2022
1	Immunomodulating AgentsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	C-Reactive ProteinIBA 10/2021
1	Ranitidine (Zantac)FDA LinkGeneric 01/2021
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2021
1	Famotidine (Pepcid)FDA LinkGeneric 01/2021
1	tegoprazanIBA 01/2021
1	rebamipideIBA 01/2021
1	polaprezinc (Z 103)IBA 01/2021
1	PotassiumIBA 01/2021
1	IntegrinsIBA 01/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2019
1	AlginatesIBA 11/2019
1	CalciumIBA 10/2019
1	vasectrin IIIIBA 07/2019
1	TrimebutineIBA 10/2018
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 06/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2017
1	C-Type Lectins (C-Type Lectin)IBA 02/2017
1	HDL LipoproteinsIBA 01/2017

Therapy/Procedure

6	Myotomy 04/2022 - 01/2016
5	Therapeutics 01/2016 - 04/2013
4	Stents 05/2020 - 01/2013
3	Aftercare (After-Treatment) 06/2021 - 04/2013
3	Chemoradiotherapy 03/2021 - 01/2014
3	Self Expandable Metallic Stents 05/2020 - 01/2013
3	Radiotherapy 01/2019 - 01/2012
2	Drug Therapy (Chemotherapy) 05/2022 - 03/2014
2	Gastrectomy 10/2021 - 03/2014
2	Colectomy 01/2013 - 08/2005
1	Length of Stay 10/2021
1	Heller Myotomy 07/2019
1	Endoscopic Hemostasis 01/2018